| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo; the Department of Cell Growth and Regulation,* Institute of Molecular and Cellular Biosciences, and Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo; and the Glycogene Function Team of Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan
Tumor cell-induced platelet aggregation has been reported to facilitate hematogenous metastasis. Aggrus/podoplanin is a platelet aggregation-inducing factor that is up-regulated in a number of human cancers and has been implicated in tumor progression. We studied herein the role of Aggrus in tumor growth, metastasis, and survival in vivo. Aggrus expression in Chinese hamster ovary cells promoted pulmonary metastasis in both an experimental and a spontaneous mouse model. No differences in the size of metastatic foci or in primary tumor growth were found in either set of mice. Aggrus-expressing cells, which were covered with platelets, arrested in the lung microvasculature 30 minutes after injection. In addition, lung metastasis resulting from Aggrus expression decreased the survival of the mice. By generating several Aggrus point mutants, we revealed that point mutation at the platelet aggregation-stimulating domain of Aggrus (Thr34 and Thr52) obliterated both platelet aggregation and metastasis. Furthermore, administration of aspirin to mice reduced the number of metastatic foci. These results indicate that Aggrus contributes to the establishment of metastasis by promoting platelet aggregation without affecting subsequent growth. Thus, Aggrus could serve as an ideal therapeutic target for drug development to block metastasis.
This article has been cited by other articles:
 |
|
 |
|
  J. A. Abrams, P. C. Lee, J. L. Port, N. K. Altorki, and A. I. Neugut Cigarette Smoking and Risk of Lung Metastasis from Esophageal Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2707 - 2713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Navarro, R. E. Perez, M. Rezaiekhaligh, S. M. Mabry, and I. I. Ekekezie T1{alpha}/podoplanin is essential for capillary morphogenesis in lymphatic endothelial cells Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L543 - L551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Vanderbilt, L. Allen, R. F. Gonzalez, Z. Tigue, J. Edmondson, D. Ansaldi, A. M. Gillespie, and L. G. Dobbs Directed Expression of Transgenes to Alveolar Type I Cells in the Mouse Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 253 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nakazawa, S. Sato, M. Naito, Y. Kato, K. Mishima, H. Arai, T. Tsuruo, and N. Fujita Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis Blood, September 1, 2008; 112(5): 1730 - 1739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. L. Choi, K. Takeuchi, M. Soda, K. Inamura, Y. Togashi, S. Hatano, M. Enomoto, T. Hamada, H. Haruta, H. Watanabe, et al. Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non-Small Cell Lung Cancer Cancer Res., July 1, 2008; 68(13): 4971 - 4976. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
